The interplay between cortisol, inflammation, and disease underscores the need for effective stress management to enhance ...
In the cell, the hormone acts by binding to the glucocorticoid receptor (GR), which then acts as a transcription factor to ...
On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...
Infections, chemicals, stress – these environmental factors influence the risk of developing psychiatric or neurological disorders, especially if they occur before birth. The biological mechanisms ...
Hosted on MSN2mon
Neurocrine announces FDA approval of crenessityNeurocrine (NBIX) Biosciences announced the U.S. FDA has approved crenessity capsules and oral solution as an adjunctive treatment to glucocorticoid replacement to control androgens in adult and ...
Boys and young adult male patients with congenital adrenal hyperplasia receiving glucocorticoid treatment have lower bone ...
The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...
There are multiple chapters near you. Select your preferred chapter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback